Implications of IDH mutations on immunotherapeutic strategies for malignant glioma

by Choi, B.D, Curry, W.T, Kitagawa, Y., Miller, J.J, Richardson, L.G, Wakimoto, H.
Published 2022

Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative 11C-Methionine PET Uptake in Glioma Surgery

by Hara, S., Inaji, M., Ishii, K., Kobayashi, D., Maehara, T., Nariai, T., Sakuma, I., Shimizu, K., Sugawara, T., Tamura, K., Tanaka, Y., Wakimoto, H.
Published 2022

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

by Patel, A. P., Tirosh, I., Trombetta, J. J., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., Louis, D. N., Rozenblatt-Rosen, O., Suva, M. L., Bernstein, Bradley E., Regev, Aviv, Shalek, Alex K.
Published 2015

Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas

by Wakimoto, H., Tanaka, S., Curry, W. T., Loebel, F., Zhao, D., Tateishi, K., Chen, J., Klofas, L. K., Lelic, N., Kim, J. C., Dias-Santagata, D., Ellisen, L. W., Borger, D. R., Fendt, Sarah-Maria, Batchelor, Tracy T., Iafrate, A. John, Cahill, D. P., Chi, A. S., Vander Heiden, Matthew G.
Published 2015